Endothelitis in cardiac allograft biopsy specimens: Possible relationship to antibody-mediated rejection

Size: px
Start display at page:

Download "Endothelitis in cardiac allograft biopsy specimens: Possible relationship to antibody-mediated rejection"

Transcription

1 ORIGINAL CLINICAL SCIENCE Endothelitis in cardiac allograft biopsy specimens: Possible relationship to antibody-mediated rejection Fabio Tavora, MD, a Raghava Munivenkatappa, MD, b John Papadimitriou, MD, b Cinthia Drachenberg, MD, b Charles Sailey, MD, b Mandeep Mehra, MD, b and Allen Burke, MD b From a Messejana Heart and Lung Hospital, Fortaleza Brazil; the b University of Maryland Medical Center, Baltimore, Maryland. KEYWORDS: heart transplantation; antibody mediated rejection; endothelitis; vasculitis; complement BACKGROUND: The incidence of endothelitis in cardiac transplants, and the relationship to clinical symptoms and humoral rejection, is unclear. Recently, the finding of intravascular macrophages has been found to represent antibody-mediated rejection. This study investigated the role of intravascular T lymphocytes in antibody-mediated rejection. METHODS: A total of 819 sequential biopsy specimens from 93 cardiac allograft recipients were prospectively studied. Rejection was graded according to International Society for Heart and Lung Transplantation (ISHLT) criteria and inflammatory infiltrates characterized by immunohistochemical staining for CD3, CD4, CD8, CD68, and CD20. Endothelitis was defined as lymphocyte and macrophage infiltrates within arteriolar, capillary, or venular walls, with endothelial swelling, in contrast to perivascular inflammation of cellular rejection. Complement C4d was identified in capillary walls by immunofluorescent staining and immunohistochemical staining on paraffin sections. RESULTS: Endothelitis was identified in 27 specimens (3%) from 14 patients (15%). ISHLT rejection grades were 0 in 6 specimens, 1R in 20 (1A in 8; 1B in 12), and 2R (3A) in 1. In all cases, there were admixtures of macrophages and T lymphocytes. Inflammation was most prominent in venules. C4d was localized in 12 of the 27 specimens (44%). C4d was localized in 31 of 796 specimens without endothelitis (p 0.001). The endothelial infiltrates were CD3, CD4, CD8, and CD68. Twelve of 14 patients had 0 panel reactive antibodies (PRA), 9 were above 10%, and 8 were above 25%; 5 patients were treated for clinical antibody-mediated rejection, and 4 had possible cardiac allograft vasculopathy by ultrasound imaging (mean follow-up, 40 ). CONCLUSION: Endothelitis is present in more than 10% of heart transplant recipients and is associated with complement deposition on biopsy samples. Approximately 33% of patients have clinical evidence of humoral rejection. The eventual risk for developing graft vascular disease remains undetermined. J Heart Lung Transplant 2011;xx:xxx 2011 International Society for Heart and Lung Transplantation. All rights reserved. Antibody-mediated rejection (AMR) results from complement-mediated endothelial damage in the allograft. Initial AMR was considered to be essentially devoid of inflammation characteristic of cellular rejection. However, the intraluminal macrophages and neutrophils are currently recognized histologic features. Nevertheless, the diagnostic criteria for antibody AMR varies from center to center, and Reprint requests: Allen Burke, MD, University of Maryland Medical Center, 22 S Greene St, Baltimore, MD Telephone: address: allen.burke@gmail.com /$ -see front matter 2011 International Society for Heart and Lung Transplantation. All rights reserved. doi: /j.healun the incidence differs according to patient population and methods of diagnosis, which depend on clinical, serologic, and immunohistochemical findings. Despite the revision of the International Society for Heart and Lung Transplantation (ISHLT) panel, there is no consensus on histologic features and immunohistochemical findings of complement deposition that define AMR. Endothelitis is defined as intimal inflammation in muscular arteries (arteritis), arterioles, and capillaries (capillaritis), and is diagnosed in heart transplant biopsy specimens when there is arteriolar and capillary inflammation.

2 2 The Journal of Heart and Lung Transplantation, Vol xx, No x, Month 2011 Table 1 Clinical Characteristics of Patients With Endothelitis Patient Age at transplant (years) Sex Indication LVAD Immunosuppression 1 20 F NICM Yes Tac, MMF, Pred 2 22 F Post-partum Yes Tac, MMF, Pred 3 22 F Post-partum No Tac, MMF, Pred 4 27 M NICM No Tac, MMF, Pred 5 47 M NICM Yes Tac, MMF, Pred 6 50 F NICM No Tac, MMF, Pred 7 51 M NICM Yes Tac, MMF, Pred 8 60 M Ischemic Yes Cyc, Pred, MMF 9 60 M Ischemic No Tac, MMF, Pred M Ischemic Yes Tac, MMF, Pred M Ischemic No Tac, Sir, Pred M Ischemic Yes Tac, MMF, Pred M NICM (valvular, rheumatic) No Cyc, Pred, MMF M Ischemic No Cyc, Pred, MMF F, female; LVAD, left ventricular assist device; M, male; MMF, mycophenolate mofetil; NICM, non-ischemic cardiomyopathy; Pred, prednisone; Sir, sirolimus; Tac, tacrolimus. Autopsy studies long ago described necrotizing vasculitis associated with intimal thickening and complement deposition. 1 Anecdotal evidence suggests that vasculitis involves the entire coronary tree, from epicardial to small intramural branches. 2 Also termed intimitis, especially in renal transplants, 3 endothelitis has been described in epicardial arteries in autopsies of heart allografts as a possible precursor lesion to cardiac allograft vasculopathy (CAV). Intimitis or endothelitis in the cardiac transplants has been associated with cytomegalovirus infection 4 and the development of CAV based on autopsy studies. 5,6 Figure 1 Endothelitis is shown in endomyocardial biopsy specimens of a small arteriole. (A) Hematoxylin-eosin stained section of an arteriole with chronic inflammation within the lumen and wall of the vessel. (B) CD4 immunohistochemical staining shows T lymphocytes infiltrating the wall of the arteriole. (C) CD8 immunohistochemical staining shows T lymphocytes infiltrating the wall of the arteriole. Original magnification 400.

3 Tavora et al. Endothelitis and Antibody Mediated Rejection 3 Although perivascular inflammation is a hallmark of low-grade cellular rejection, intimal inflammation and endothelial reaction is not mentioned as a component of lowgrade cellular rejection. 7 Vasculitis is considered only a component of severe rejection with myocyte necrosis. The coexistence of cellular and AMR has, however, been well documented. In the revised ISHLT criteria for biopsy specimen diagnosis, intravascular macrophages have been identified as a typical feature of AMR, as well as vascular neutrophils. 7 Vasculitis, including lymphocytic inflammation, is not considered in these revised criteria as a separate diagnosis or one associated with AMR. The purpose of the current study was to provide a workable definition of endothelitis (intimitis) on heart biopsy specimens in patients without high-grade rejection, and determine the incidence and clinical significance, especially related to AMR, and histologic evidence of complement deposition. Material and methods All heart allograft biopsy specimens at the University of Maryland Medical Center were prospectively entered into a database during a 4-year period from 2004 to Cases with 2 biopsy fragments with myocardium were retained for study. Institutional Investigational Review Board approval was obtained for the research. Recorded data at the time of biopsy were grade of rejection, presence of endothelitis, Quilty effect, and prior biopsy site. Before 2006, cellular rejection was graded according to the 1990 working formulation of the ISHLT, and after 2006, by the older grading system as well as the 2005 revision. 7 Quilty was defined as the presence of discrete aggregate of endothelial T lymphocytes, with or without central B cells. Tangentially sectioned subendocardial infiltrates were diagnosed as cellular rejection vs Quilty by CD20 infiltrates, appearance on different levels, and consensus agreement by 2 of the study pathologists (A.P.B., C.I.D.). Immunohistochemical stains were done by Ventana automated immunostainer. C4d antibody was commercially obtained from Thermo Scientific, Waltham, Massachusetts. A dilution of 1:200 was used, with staining on an automated Ventana Immunostainer. C4d positivity was defined as 50% of capillaries with distinct endothelial staining. Each specimen was stained at 3 levels for hematoxylineosin, with additional levels for immunostains. Endothelial markers CD31, CD34, and factor VIII-related antigen were assessed by immunohistochemistry on those cases assessed as endothelitis or possible endothelitis. In addition, CD3, CD4, and CD8 immunohistochemical stains were performed. Endothelitis was defined in distinction to perivascular cellular inflammation by intravascular or capillary inflammation with endothelial cell reaction, characterized by nuclear enlargement. Endothelial markers were used to identify inflammatory cells within the lumen and wall of the vessel. The distinction of interstitial cellular rejection (old 1A, or 1R) was based on intravascular inflammation or sub-endothelial infiltration with endothelial cell swelling. Clinical information obtained in patients diagnosed with endotheliitis included duration of transplant, graft function, presence of panel reactive antibodies, and presence of donor-specific antibodies. Follow-up data included development of subsequent rejection or AMR, CAV, graft failure, or death. Duration of transplant was recorded in all biopsy specimens as well as indication for biopsy (surveillance vs suspicion of rejection). Results There were 839 biopsies in 93 patients in the study period that met the inclusion criteria. The 93 patients comprised 71 men (age, years) and 22 women (age, years; p vs men) at time of transplant. The mean numbers of biopsies during the study period per patient was 8 4 for men, and 11 4 for women (p 0.02 vs. men). The mean duration of transplant at the last biopsy was for men and for women. Of the 93 patients, 3 of 22 women and 22 of 71 men showed no evidence of rejection on any biopsy specimen (p 0.1, men v. women), 14 of 22 women and 39 of 71 men showed evidence of Quilty on 1 specimens (p 0.5, men vs women), and 14 (4 women, 10 men) showed evidence of endothelitis on 1 biopsy, for a total of 27 biopsies. Their ages at time of transplant ranged from 20 to 67 years (Table 1). The indication for transplant and presence of prior LVAD are presented in Table 1. Most patients were on an immunosuppressive regimen of tacrolimus, mycophenolate mofetil (MMF), and prednisone (Table 1). Twelve of the 14 had evidence of alloantibodies (Table 1), 10 10% and 9 25%. Nine of the 14 had donor-specific antibodies, including 5 with major histocompatibility complex class 2 (Table 1). The histologic features of endothelitis were primarily intravascular macrophages in 3, with an admixture of T cells and macrophages in the remaining 24. The lymphocytes expressed CD3 by immunohistochemical staining, with a predominance of CD4-positive T cells in each of the 24 cases (Figures 1 and 2). CD31, CD34, and factor VIII immunohistochemical stains demonstrated intraluminal inflammatory cells and occasionally inflammatory cells that were surrounded by endothelial cell cytoplasm (Figure 3). There was a sub-population of CD8- positive cells in 21 of the 24 cases with intravascular T cells (Figures 2 and 4). The vessels involved were small arterioles (Figure 1), venules (Figures 2 5), and capillaries (Figure 5). The media of vessels was often not intact due to infiltration of the vessel cross-section by inflammation, rendering the distinction between small arteriole and capillary difficult in some cases. In most specimens there was a mixture of inflammatory cells, including macrophages and lymphocytes, within the vascular lumens in a given specimen, although 1 patient had primarily lymphocytic endothelitis in 1 biopsy specimen and macrophages in a subsequent biopsy (Figure 5). In general, the larger vessels were more likely to have a predominant lymphocytic infiltration, with capillaries more predominantly macrophages, although even capillaries had a significant proportion of lymphocytes in most cases (Figure 4). C4d staining was present in 10 of the patients with specimens with endothelitis and in 12 of the specimens with endothelitis (Table 2). There was no significant correlation with serologic results of panel reactive antibodies or donorspecific antibodies (Table 2). Even in the biopsy specimens with predominant intravascular macrophages, there was a lymphocytic endothelitic component (Figure 5) as well as perivascular inflammation

4 4 The Journal of Heart and Lung Transplantation, Vol xx, No x, Month 2011 Figure 2 Endothelitis is shown in endomyocardial biopsy specimens of venules. (A) Hematoxylin-eosin stained section shows marked expansion of the vessel by chronic inflammation obscuring the lumen and wall of the vessel. Occasional red blood cells are noted in the lumen. (B) CD4 immunohistochemical staining shows T lymphocytes infiltrating the vessel wall. (C) CD68 immunohistochemical staining shows a minor subpopulation of macrophages in the infiltrate. CD8 immunohistochemical staining shows T lymphocytes infiltrating the vessel walls. Original magnification 400. Figure 3 Endothelitis is shown in venules. (A) Immunohistochemical staining for CD34 of the vessel in the specimen shown in Figure 2 demonstrates endothelial cells in the intima surrounded by chronic inflammation but within the lumen as well as surrounding the vessel. Original magnification 200. (B) Immunohistochemical staining for CD31 of vessel shown in Figure 2 demonstrates endothelial cells in the intima surrounded by chronic inflammation, but within the lumen as well as surrounding the vessel. Original magnification 200. (C) Immunohistochemical staining for factor VIII-related antigen demonstrates endothelial cells in the intima with chronic inflammatory cells (not staining) on the intimal luminal surface. Original magnification 400.

5 Tavora et al. Endothelitis and Antibody Mediated Rejection 5 Figure 4 Lymphocytic vasculitis, with C4d deposition, is shown in capillaries and venules. (A, original magnification 200, B, original magnification 400 ) Hematoxylin and eosin staining demonstrates lymphocytes not only in a perivascular distribution, as seen in mild rejection, but also within venular walls. (C) CD8 immunohistochemical stain has identified T lymphocytes within the vessel. Original magnification 400. (D) C4d immunohistochemical staining is shown for endothelial complement. Original magnification 200. (Figures 6 and 7). This perivascular infiltrate was considered a component of cellular rejection if extensive. Patients with endothelitis on biopsy specimens were a mean years (range 2 weeks 5 years) after transplant vs years for others (p 0.3 Wilcoxon rank sum test for non-parametric data). The number of specimens showing endothelitis in patients with 1 positive biopsy specimen ranged from 1 in 16 (6%) to 3 in 6 specimens (50%). Thirteen of the 14 patients with endothelitis on any specimen demonstrated rejection on any biopsy, and of the individual 23 biopsy specimens in these patients, 20 of 23 showed cellular rejection. Nine of these were assigned ISHLT grade 1R, 1B; and the remaining 14 showed grade 1R, 1A. Eight of 12 patients with endothelitis on any biopsy specimen demonstrated C4d positivity in an endothelial pattern; in all but 1 patient, C4d was seen only in specimens with endothelitis. Of the 27 biopsy specimens with endothelitis, 12 (44%) showed endothelial staining for C4d. On follow-up (40 9 ), 4 patients had possible CAV, one with symptomatic CAV (Table 3). One patient died of infection and sepsis 2.5 years after transplant. The 3 patients with biopsy specimens showing primarily intravascular macrophages (Patients 1, 10, and 14, Table 2) all showed clinical evidence of AMR, 1 progressing to CAV as evidenced by intravascular ultrasound, and 1 with possible CAV. In 2 of the patients, there were other specimens with predominantly lymphocytic endothelitis. Compared with patients without endothelitis on any biopsy specimen, the duration of transplant at the last biopsy was less long and the incidence of rejection was higher, at borderline significance (Table 4). Discussion The current study shows that the rate of endothelitis is 15% for patients and 3% for heart biopsy specimens. The higher rate by patient indicates that recurrence is typical, because in the 12 patients, there was a range of 6% to 50% of the proportion of biopsy specimens with endothelitis. There was a high association with cellular rejection, especially low grade (particular

6 6 The Journal of Heart and Lung Transplantation, Vol xx, No x, Month 2011 Figure 5 (A) Capillaries and small arterioles are expanded and filled with CD68-positive macrophages with (B) diffuse endothelial staining for C4d. The patient had a history of antibody-mediated rejection and evidence of lymphocytic vasculitis on biopsy specimens 2 years prior. (C) The routinely stained section shows mild interstitial inflammation, with (D) a population of T lymphocytes around capillaries (anti-cd3 avidin-biotin technique). Original magnification 400. Table 2 Immunohistochemical and Serologic Data for Patients With Endothelitis PRA, % DSA Patient C4d IHC endothelitis (other biopsies) C4d MHC 1 MHC 2 Class 1/class 2 1 1/2 endothelitis (0/12 other) 0 0 No 2 1/1 endothelitis (0/15 other) 36 3 No Yes (both) Yes (1) 5 2/5 endothelitis (0/10 other) 9 40 Yes (2) 6 2/3 endothelitis (2/7 other) 41 2 Yes (1) 7 1/1 endothelitis (0/14 other) Yes (both) 8 1/1 endothelitis (0/15 other) 6 0 Yes (2) 9 1/2 endothelitis (0/8 other) 17 0 Yes (both) Yes (1) 11 1/3 endothelitis (0/3 other) 5 0 No No 13 1/1 endothelitis (0/9 other) 0 6 No 14 1/3 endothelitis (0/3 other) Yes (2) IHC, immunohistochemistry; MHC, major histocompatibility complex; PRA, panel reactive antibody; DSA, donor-specific antibodies.

7 Tavora et al. Endothelitis and Antibody Mediated Rejection 7 Figure 6 Perivascular inflammation associated with endothelitis in a patient with clinical antibody-mediated rejection. (A) There is extensive perivascular inflammation with macrophages (CD68 stain). Original magnification 200. (B) A higher magnification of a different area shows intra-arteriolar macrophages (arrows). Original magnification, 400. (C) CD3 immunohistochemical stain shows diffuse interstitial T lymphocytes associated with capillaries in a pattern of 1B rejection. Original magnification, 200. (D) A venule from the same specimen shows diffuse infiltration of the vessel wall by macrophages (CD68; immunohistochemistry, avidin-biotin technique). Original magnification, 400. Figure 7 Perivascular inflammation associated with endothelitis. (A) A low magnification image stained for CD3 T lymphocytes shows a pattern similar to 1B rejection. Original magnification, 100. (B) Scattered vessels demonstrated intense infiltration with T lymphocytes. Original magnification 200. (C) Immunohistochemical staining for CD68 shows clear intravascular macrophages. Original magnification 200.

8 8 The Journal of Heart and Lung Transplantation, Vol xx, No x, Month 2011 Table 3 Follow-up Data for Patients With Endothelitis Patient Endothelitis biopsies/total biopsies Time post-tx endothelitis biopsies Range of cellular rejection (biopsies/ total) History of AMR or CAV IVUS Follow-up. 1 2/14 primarily macrophages 2 week 1 month ISHLT 1 and 2, 8/14 Possible CAV Possible mild vessel narrowing Lost to follow-up at /16 2 All ISHLT 1, 8/16 No Mild distal vessel narrowing Died 2 years 6 3 1/15 2 weeks 14 Multiple episodes AMR ISHLT 1 and 2, 6/15, same as mild Normal IVUS; significant biventricular dysfunction 4 2/5 2 weeks ISHLT 1 and 2, 3/5 No IVUS, normal dobutamine stress echo Rejection 3B, endothelitis, AMR 4 years 4 OK / All ISHLT 1, 8/15 No None OK 4 years 1 month 6 3/10 2 weeks 3 ISHLT 1, 1/10, AMR with RV No OK 7 different biopsy dysfunction 7 1/15 2 ISHLT 1, 1/14 (different biopsy) AMR, post- transplant plasmapheresis Minimal intimal hyperplasia; normal ejection fraction OK 3 years 8 recent normal biopsies 8 1/16 10 ISHLT 1 (endothelitis) and 2, 2/16 9 2/10 2 ISHLT 1 and 2, 8/10 Episodes of cellular rejection (noncompliance) No No OK 2 years 6 No OK /3 primarily 1 month ISHLT 1 (same B-cell cross match; No OK at 14 macrophages biopsy) severe non-hla AMR 11 3/ All ISHLT 1, 4/6 No Normal IVUS Doing well, 7 years 1 month 12 1/3 2 0 No No Persistent endothelitis, /10 12 All ISHLT 1, 6/10 No None OK 7 years /6 primarily macrophages in 1 biopsy ISHLT 1, 2/6 Multiple episodes AMR; CAV with severe LV dysfunction CAV AMR clinically 11 years 3, with endothelitis AMR, antibody-mediated rejection; CAV, cardiac allograft vasculopathy; HLA, human leukocyte antigen; ISHLT, International Society for Heart and Lung Transplantation; IVUS, intravascular ultrasound; LV, left ventricular; RV, right ventricular. previous grade 1B). The inflammation within vessels that defined endothelitis was often associated with perivascular inflammation, explaining at least in part the association with cellular rejection. Furthermore, old 1B rejection, as defined by diffuse increased inflammation without discrete infiltrates, may be an overlap condition with endothelitis. The relationship between cellular rejection, endothelitis, and AMR is not clear. The current study defined endothelitis as separate from perivascular infiltrates of mild rejection by involvement of the vessel wall, namely, subintimal inflammation, luminal inflammation, and endothelial reaction. None of the patients had severe rejection, which is associated with vascular necrosis. Of interest, the current study showed that the nature of the inflammatory infiltrates was most typically lymphocytic, as opposed to macrophage cells, which have been proposed as a criterion, when intraluminal, for AMR. 7 The current study showed an association between C4d capillary deposition and endothelitis, because there was a significantly increased rate of C4d-positive reaction in the endothelitis specimens compared with others, and there was a clear association, among patients with endothelitis, between episodes of vasculitis and complement deposition. However, almost 33% of biopsy specimens with endothelitis showed no complement deposition. It is unknown if endothelitis with complement represents a non-immune mechanism of endothelial inflammation, whether other forms of complement, such as C3d are present, or if there is a temporal difference between

9 Tavora et al. Endothelitis and Antibody Mediated Rejection 9 Table 4 Comparison of Clinical Features of Patients With and Without Endothelitis on any Biopsy Specimen No Endothelitis endothelitis Feature a (n 14) (n 79) p-value Age at last biopsy, years Sex, No. 0.6 Male Female 4 18 Biopsies, No Duration of transplant, Incidence on any biopsy, No. Rejection 13/14 55/79.04 Quilty 8/14 45/ C4d staining 10/14 7/ a Continuous data are shown as the mean standard deviation. inflammation and complement deposition in some patients. Using histologic findings for the diagnosis of AMR has some limitations. The current criteria suggest that intravascular macrophages, endothelial swelling, neutrophils, hemorrhage, and edema are evidence for AMR, as well as C4d deposition. 7 In the current study, endothelitis was characterized primarily by macrophage and lymphocytic infiltrates and endothelial swelling. The latter finding is less specific and reproducible than the finding of intimal inflammatory cells, with the use of endothelial markers. The known problems with standardization of complement deposition include the antibody used, fixation, immunohistochemical technique, and use of C4d vs C3d. In the current study, no case showed neutrophils, hemorrhage, or edema, features that are often associated with severe cellular rejection. 8,9 It is unclear why neutrophils were not seen in any case of endothelialitis in the current study, which is a common feature of capillaritis in the kidney. 10 In renal biopsies, a quantitative scoring method is used for C4d deposition as well as capillaritis. 10 The method is based on the proportion of peritubular capillaries with inflammation, the overall number of luminal inflammatory cells, and the proportion of capillaries staining positive ( 50% generally considered positive). The current study documented a strong correlation between capillaritis and C4d deposition, as has been shown in the kidney. A scoring pattern similar to that in the kidney may eventually be applicable to the heart. It is unclear if both lymphocytic endothelitis and intravascular macrophages are different stages of AMR or separate processes. Because of overlap of both findings in the same biopsy specimens as well as in different specimens of the same patients, the current study suggests that they are both manifestations of AMR. Interestingly, intracapillary macrophages were seen in patients with clinical AMR, indicating the possibility that this represents a later phase in endothelitis. Similar to allograft rejection in kidneys, it may be useful to grade AMR in heart biopsy specimens by the degree of vascular inflammation, beginning with scattered intimal lymphocytes, progressing to diffuse lymphocytic endothelitis, and culminating in intimitis with intravascular macrophages. Because endothelitis often has perivascular inflammation, concomitant mild rejection (grade 1R) is commonly seen in association, as the current study shows. The diagnosis of endothelitis rests on intravascular and subintimal lymphocytes and macrophages with an endothelial reaction, features absent in cellular rejection. Diffuse inflammation within capillary vessels, without significant perivascular inflammation, was present in some of the cases presented in the current study and has morphologic overlap with previously designated low-grade cellular rejection 1B. Clinical evidence of AMR in the current study was present in 5 of 14 patients, and serologic evidence (PRA 10%) in 9 of 14 patients. These data suggest that endothelitis is associated with the development of graft dysfunction through an antibody-mediated mechanism. The relationship between endothelitis and epicardial coronary disease is less clear. However, vasculitis as a component of cardiac allograft rejection has been described for more than 10 years. Berglin et al 11 described 5 of 151 patients with lymphocytic vasculitis on heart biopsy specimens, which was associated with severe graft dysfunction and response to plasmapheresis. The current study supports the concept that lymphocytic infiltration of small vessels in heart biopsy specimens may be a component of humoral rejection or AMR. 11 The presence at autopsy of vasculitis has been associated with cyclosporine and to the subsequent development of graft vasculopathy. 5,12 In the current study, arterioles, venules, and capillaries were involved, generally in the same biopsy specimen. In addition, an overlap was found between primarily macrophage and lymphocytic infiltration of vessels in the same specimen as well as temporally among biopsy specimens in a given patient. In conclusion, intimal inflammation in cardiac allograft biopsy specimens comprises not only macrophages but T lymphocytes as well and may be suggestive of AMR and may occur at a relatively frequent rate. The relationship between the future development of CAV needs further study. Disclosure statement None of the authors has a financial relationship with a commercial entity that has an interest in the subject of the presented manuscript or other conflicts of interest to disclose. References 1. Foerster A. Vascular rejection in cardiac transplantation. A morphological study of 25 human cardiac allografts. APMIS 1992;100:

10 10 The Journal of Heart and Lung Transplantation, Vol xx, No x, Month Cuda JD, Baldwin WM 3rd, Steenbergen C, Judge DP, Dropulic LK, Halushka MK. Extensive cardiac allograft vasculitis and concurrent fat necrosis 6 years after orthotopic heart transplantation. J Heart Lung Transplant 2007;26: Emovon OE, King JA, Smith SR, et al. Clinical significance of eosinophils in suspicious or borderline renal allograft biopsies. Clin Nephrol 2003;59: Koskinen P, Lemstrom K, Bruggeman C, Lautenschlager I, Hayry P. Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. A possible linkage with enhanced allograft arteriosclerosis. Am J Pathol 1994;144: Paavonen T, Mennander A, Lautenschlager I, Hayry P. Endothelialitis in accelerated allograft arteriosclerosis in human cardiac transplant recipients. Transplant Proc 1992;24: Paavonen T, Mennander A, Lautenschlager I, Mattila S, Hayry P. Endothelialitis and accelerated arteriosclerosis in human heart transplant coronaries. J Heart Lung Transplant 1993;12: Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005;24: Berry GJ, Brunt EM, Chamberlain D, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990;9: Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990;9: Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008;8: Berglin E, Kjellstrom C, Mantovani V, Stelin G, Svalander C, Wiklund L. Plasmapheresis as a rescue therapy to resolve cardiac rejection with vasculitis and severe heart failure. A report of five cases. Transpl Int 1995;8: Mennander A, Paavonen T, Hayry P. Cyclosporine-induced endothelialitis and accelerated arteriosclerosis in chronic allograft rejection. Transplant Proc 1992;24:341.

Interstitial Inflammation

Interstitial Inflammation Interstitial Inflammation Currently considered to be T cell-mediated process Plasma cell rich acute rejection often associated with AMR Preliminary data suggests that interstitial follicular helper T cells

More information

Antibody Mediated Rejection (AMR) in Heart Transplantation Session

Antibody Mediated Rejection (AMR) in Heart Transplantation Session Page 1 Antibody Mediated Rejection (AMR) in Heart Transplantation Session Dear Colleagues: The Heart session at Banff this year will be solely focused on AMR and besides the fact that many of us attending

More information

No evidence of C4d association with AMR However, C3d and AMR correlated well

No evidence of C4d association with AMR However, C3d and AMR correlated well C4d positivity Poor prognostic factor Reversal to C4d negativity did not change prognosis, with current therapy Prognostic factor for CAV Variable time line for CAV/death No correlation with cellular rejection

More information

Antibody Mediated Rejection (AMR) in LUNG TRANSPLANT Recipients

Antibody Mediated Rejection (AMR) in LUNG TRANSPLANT Recipients Antibody Mediated Rejection (AMR) in LUNG TRANSPLANT Recipients Lorriana Leard, MD UCSF Transplant Pulmonologist Associate Professor of Clinical Medicine Vice Chief of Clinical Activities Pulmonary, Critical

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Lefaucheur C, Loupy A, Vernerey D, et al. Antibody-mediated

More information

Biopsy Features of Kidney Allograft Rejection Banff B. Ivanyi, MD Department of Pathology, University of Szeged, Szeged, Hungary

Biopsy Features of Kidney Allograft Rejection Banff B. Ivanyi, MD Department of Pathology, University of Szeged, Szeged, Hungary Biopsy Features of Kidney Allograft Rejection Banff 2017 B. Ivanyi, MD Department of Pathology, University of Szeged, Szeged, Hungary Treatment of allograft dysfunction should rely on the biopsy findings

More information

Banff-SCT 2017 Towards Uniformity of Terminology for the Pathology of CAV. Gerald J. Berry, MD Dept. of Pathology Stanford University Stanford, CA

Banff-SCT 2017 Towards Uniformity of Terminology for the Pathology of CAV. Gerald J. Berry, MD Dept. of Pathology Stanford University Stanford, CA Banff-SCT 2017 Towards Uniformity of Terminology for the Pathology of CAV Gerald J. Berry, MD Dept. of Pathology Stanford University Stanford, CA Objectives Review current terminology Identify key histopathologic

More information

Antibody-Mediated Rejection in the Lung Allograft. Gerald J Berry, MD Dept of Pathology Stanford University Stanford, CA 94305

Antibody-Mediated Rejection in the Lung Allograft. Gerald J Berry, MD Dept of Pathology Stanford University Stanford, CA 94305 Antibody-Mediated Rejection in the Lung Allograft Gerald J Berry, MD Dept of Pathology Stanford University Stanford, CA 94305 Gerald J Berry, MD Professor of Pathology Stanford University, Stanford, CA

More information

Management of Rejection

Management of Rejection Management of Rejection I have no disclosures Disclosures (relevant or otherwise) Deborah B Adey, MD Professor of Medicine University of California, San Francisco Kidney and Pancreas Transplant Center

More information

Renal Pathology- Transplantation. Eva Honsova Institute for Clinical and Experimental Medicine Prague, Czech Republic

Renal Pathology- Transplantation. Eva Honsova Institute for Clinical and Experimental Medicine Prague, Czech Republic Renal Pathology- Transplantation Eva Honsova Institute for Clinical and Experimental Medicine Prague, Czech Republic eva.honsova@ikem.cz Kidney has a limited number of tissue reactions by which the kidney

More information

Immunopathology of T cell mediated rejection

Immunopathology of T cell mediated rejection Immunopathology of T cell mediated rejection Ibrahim Batal MD Columbia University College of Physicians & Surgeons New York, NY, USA Overview Pathophysiology and grading of TCMR TCMR is still a significant

More information

Post-Transplant Monitoring for the Development of Anti-Donor HLA Antibodies

Post-Transplant Monitoring for the Development of Anti-Donor HLA Antibodies Post-Transplant Monitoring for the Development of Anti-Donor HLA Antibodies Lorita M Rebellato, Ph.D., D (ABHI) Associate Professor Department of Pathology The Brody School of Medicine at ECU Scientific

More information

Med Path Rads Conference Gurpreet Sodhi M.D.

Med Path Rads Conference Gurpreet Sodhi M.D. Med Path Rads Conference 5.10.13 Gurpreet Sodhi M.D. Objectives -Define and understand noncompaction cardiomyopathy -Briefly review normal intracardiac hemodynamic pressures and interpret a patient s pressures

More information

Interpretation of Renal Transplant Biopsy. Arthur H. Cohen Wake Forest University School of Medicine Winston-Salem, North Carolina USA

Interpretation of Renal Transplant Biopsy. Arthur H. Cohen Wake Forest University School of Medicine Winston-Salem, North Carolina USA Interpretation of Renal Transplant Biopsy Arthur H. Cohen Wake Forest University School of Medicine Winston-Salem, North Carolina USA Renal Transplant Biopsies Tissue Processing Ideal world process as

More information

Kidney Summary. Mark Haas Cedars-Sinai Medical Center Los Angeles, California, USA

Kidney Summary. Mark Haas Cedars-Sinai Medical Center Los Angeles, California, USA Kidney Summary Mark Haas Cedars-Sinai Medical Center Los Angeles, California, USA Key Issues to Address re: the Classification 1. Incorporation of i-ifta + tubulitis into the TCMR classification - Defining

More information

HLA and Non-HLA Antibodies in Transplantation and their Management

HLA and Non-HLA Antibodies in Transplantation and their Management HLA and Non-HLA Antibodies in Transplantation and their Management Luca Dello Strologo October 29 th, 2016 Hystory I 1960 donor specific antibodies (DSA): first suggestion for a possible role in deteriorating

More information

Pathological back-ground of renal transplant pathology and important mile-stones of the Banff classification

Pathological back-ground of renal transplant pathology and important mile-stones of the Banff classification Banff 1 Banff Pathological back-ground of renal transplant pathology and important mile-stones of the Banff classification Department of Nephrology, Japanese Red Cross Nagoya Daini Hospital Morozumi Kunio,

More information

AMR in Liver Transplantation: Incidence

AMR in Liver Transplantation: Incidence AMR in Liver Transplantation: Incidence Primary AMR 1/3 to 1/2 of ABO-incompatible transplants Uncommon with ABO-compatible transplant Secondary AMR Unknown incidence: rarely tested Why is AMR uncommon

More information

The Banff Classification for Diagnosis of Renal Allograft Rejection: Updates from the 2017 Banff Conference

The Banff Classification for Diagnosis of Renal Allograft Rejection: Updates from the 2017 Banff Conference The Banff Classification for Diagnosis of Renal Allograft Rejection: Updates from the 2017 Banff Conference Mark Haas Cedars-Sinai Medical Center Los Angeles, California, USA Statement of Disclosure Mark

More information

Antibody Mediated Rejection in Heart Transplantation

Antibody Mediated Rejection in Heart Transplantation Antibody Mediated Rejection in Heart Transplantation 2012 Teresa De Marco, MD, FACC Professor of Medicine & Surgery Director Heart Failure and Pulmonary Hypertension Program Medical Director, Heart Transplantation

More information

Heart Transplantation ACC Middle East Conference Dubai UAE October 21, 2017

Heart Transplantation ACC Middle East Conference Dubai UAE October 21, 2017 Heart Transplantation ACC Middle East Conference Dubai UAE October 21, 2017 Randall C Starling MD MPH FACC FAHA FESC FHFSA Professor of Medicine Kaufman Center for Heart Failure Department of Cardiovascular

More information

Statement of Disclosure

Statement of Disclosure Statement of Disclosure Mark Haas serves as a paid consultant on pathology adjudication committees for two industry-sponsored clinical trials: Shire ViroPharma Treatment of Acute ABMR AstraZeneca Treatment

More information

Intravascular macrophages in cardiac allograft biopsies for diagnosis of early and late antibody-mediated rejection

Intravascular macrophages in cardiac allograft biopsies for diagnosis of early and late antibody-mediated rejection http://www.jhltonline.org Intravascular macrophages in cardiac allograft biopsies for diagnosis of early and late antibody-mediated rejection Marny Fedrigo, MD, PhD, a Giuseppe Feltrin, MD, PhD, a Francesca

More information

Chronic injury to the microcirculation in EMB

Chronic injury to the microcirculation in EMB Chronic injury to the microcirculation in EMB Dylan V Miller MD M Patricia Revelo MD Disclosures Miller: None Revelo: None Goals & Objectives Characterize the tissue-level pathologic changes occurring

More information

Pathology of Kidney Allograft Dysfunction. B. Ivanyi, MD Department of Pathology, University of Szeged, Szeged, Hungary

Pathology of Kidney Allograft Dysfunction. B. Ivanyi, MD Department of Pathology, University of Szeged, Szeged, Hungary Pathology of Kidney Allograft Dysfunction B. Ivanyi, MD Department of Pathology, University of Szeged, Szeged, Hungary The gold standard for exploration of the cause of an allograft dysfunction is to perform

More information

Review of Rituximab and renal transplantation. Dr.E Nemati. Professor of Nephrology

Review of Rituximab and renal transplantation. Dr.E Nemati. Professor of Nephrology Review of Rituximab and renal transplantation Dr.E Nemati Professor of Nephrology Introductio n Rituximab is a chimeric anti-cd20 monoclonal antibody. The CD20 antigen is a transmembrane nonglycosylated

More information

Acute renal failure (ARF) in the transplanted kidney represents a

Acute renal failure (ARF) in the transplanted kidney represents a Acute Renal Failure in the Transplanted Kidney Kim Solez Lorraine C. Racusen Acute renal failure (ARF) in the transplanted kidney represents a high-stakes area of nephrology and of transplantation practice.

More information

Research Article The Diagnostic Value of Transcription Factors T-bet/GATA3 Ratio in Predicting Antibody-Mediated Rejection

Research Article The Diagnostic Value of Transcription Factors T-bet/GATA3 Ratio in Predicting Antibody-Mediated Rejection Clinical and Developmental Immunology Volume 2013, Article ID 460316, 6 pages http://dx.doi.org/10.1155/2013/460316 Research Article The Diagnostic Value of Transcription Factors T-bet/GATA3 Ratio in Predicting

More information

RENAL EVENING SPECIALTY CONFERENCE

RENAL EVENING SPECIALTY CONFERENCE RENAL EVENING SPECIALTY CONFERENCE Harsharan K. Singh, MD The University of North Carolina at Chapel Hill Disclosure of Relevant Financial Relationships No conflicts of interest to disclose. CLINICAL HISTORY

More information

The new Banff vision of the role of HLA antibodies in organ transplantation: Improving diagnostic system and design of clinical trials

The new Banff vision of the role of HLA antibodies in organ transplantation: Improving diagnostic system and design of clinical trials The new Banff vision of the role of HLA antibodies in organ transplantation: Improving diagnostic system and design of clinical trials Carmen Lefaucheur 1 2 Banff 2015: Integration of HLA-Ab for improving

More information

Interpretation of Biopsy Findings in the Transplant Liver

Interpretation of Biopsy Findings in the Transplant Liver Interpretation of Biopsy Findings in the Transplant Liver Kirk D. Jones, MD and Linda D. Ferrell, MD W i several thousand liver transplants being performed each year and many patients being managed in

More information

PCI in Patients with Transplant Coronary Artery Disease. Michael S. Lee, MD, FACC, FSCAI Assistant Professor UCLA School of Medicine

PCI in Patients with Transplant Coronary Artery Disease. Michael S. Lee, MD, FACC, FSCAI Assistant Professor UCLA School of Medicine PCI in Patients with Transplant Coronary Artery Disease Michael S. Lee, MD, FACC, FSCAI Assistant Professor UCLA School of Medicine Faculty Disclosure Honararia for Boston Scientific, BMS, Daiichi Sankyo,

More information

Long-term efficacy and safety of conversion to tacrolimus in heart. transplant recipients with ongoing or recurrent acute cellular.

Long-term efficacy and safety of conversion to tacrolimus in heart. transplant recipients with ongoing or recurrent acute cellular. Long-term efficacy and safety of conversion to tacrolimus in heart transplant recipients with ongoing or recurrent acute cellular rejection Blanka Skalická, Ivan Málek, Miloš Kubánek, Jevgenija Vymětalová,

More information

3/6/2017. Prevention of Complement Activation and Antibody Development: Results from the Duet Trial

3/6/2017. Prevention of Complement Activation and Antibody Development: Results from the Duet Trial Prevention of Complement Activation and Antibody Development: Results from the Duet Trial Jignesh Patel MD PhD FACC FRCP Medical Director, Heart Transplant Cedars-Sinai Heart Institute Disclosures Name:

More information

Pulmonary AMR Therapeutic Options & Strategies: The Old and the New. Ramsey Hachem, MD March 28, 2017

Pulmonary AMR Therapeutic Options & Strategies: The Old and the New. Ramsey Hachem, MD March 28, 2017 Pulmonary AMR Therapeutic Options & Strategies: The Old and the New Ramsey Hachem, MD March 28, 2017 Disclosures Ramsey Hachem I have no financial relations with any relevant commercial interests I will

More information

Solid Organ Transplant

Solid Organ Transplant Solid Organ Transplant Lee R. Goldberg, MD, MPH, FACC Associate Professor of Medicine Medical Director, Heart Failure and CardiacTransplant Program University of Pennsylvania Disclosures Thoratec Consulting

More information

Monitoring of human uterus transplantation with cervical biopsies - a provisional scoring system for rejection. Johan Mölne

Monitoring of human uterus transplantation with cervical biopsies - a provisional scoring system for rejection. Johan Mölne Monitoring of human uterus transplantation with cervical biopsies - a provisional scoring system for rejection. Johan Mölne Department of Pathology and Genetics, Sahlgrenska Academy, University of Gothenburg,

More information

Research Article The Natural History of Biopsy-Negative Rejection after Heart Transplantation

Research Article The Natural History of Biopsy-Negative Rejection after Heart Transplantation Transplantation Volume 2013, Article ID 236720, 6 pages http://dx.doi.org/10.1155/2013/236720 Research Article The Natural History of Biopsy-Negative Rejection after Heart Transplantation Zhaoyi Tang,

More information

The multidisciplinary approach to AMR in lung transplantation: Reaching a consensus. Deborah Jo Levine Professor of Medicine University of Texas

The multidisciplinary approach to AMR in lung transplantation: Reaching a consensus. Deborah Jo Levine Professor of Medicine University of Texas The multidisciplinary approach to AMR in lung transplantation: Reaching a consensus Deborah Jo Levine Professor of Medicine University of Texas Disclosures I have no financial relations with any relevant

More information

Banff Vascularized Composite Allotransplantation

Banff Vascularized Composite Allotransplantation Banff Vascularized Composite Allotransplantation Linda C. Cendales, M.D. Associate Professor of Surgery Duke Health Scholar Director, Vascularized Composite Allotransplantation Duke University Medical

More information

Correspondence should be addressed to Tor Skibsted Clemmensen;

Correspondence should be addressed to Tor Skibsted Clemmensen; Case Reports in Transplantation, Article ID 173589, 4 pages http://dx.doi.org/10.1155/2014/173589 Case Report Case of Acute Graft Failure during Suspected Humoral Rejection with Preserved Ejection Fraction,

More information

ABSTRACT AJCP /ORIGINAL ARTICLE. Downloaded from by guest on 07 January 2019

ABSTRACT AJCP /ORIGINAL ARTICLE. Downloaded from   by guest on 07 January 2019 Correlation of Circulating Complement-Fixing Donor-Specific Antibodies Identified by the C1q Assay and Presence of C4d in Endomyocardial Biopsy Specimens Renee Frank, MD, 1 Priti Lal, MD, 1 Jane Kearns,

More information

Evaluation of Biopsy Classification for Rejection: Relation to Detection of Myocardial Damage by Monoclonal Antimyosin Antibody Imaging

Evaluation of Biopsy Classification for Rejection: Relation to Detection of Myocardial Damage by Monoclonal Antimyosin Antibody Imaging 1357 HEART TRANSPLANT Evaluation of Biopsy Classification for Rejection: Relation to Detection of Myocardial Damage by Monoclonal Antimyosin Antibody Imaging MANEL BALLESTER, MD, RAMÓN BORDES, MD, HENRY

More information

Histopathology: Vascular pathology

Histopathology: Vascular pathology Histopathology: Vascular pathology These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you need to learn about these

More information

Case Presentation Turki Al-Hussain, MD

Case Presentation Turki Al-Hussain, MD Case Presentation Turki Al-Hussain, MD Director, Renal Pathology Chapter Saudi Society of Nephrology & Transplantation Consultant Nephropathologist & Urological Pathologist Department of Pathology & Laboratory

More information

Pathology of Kidney Allograft Dysfunction. B. Ivanyi, MD Department of Pathology, University of Szeged, Szeged, Hungary

Pathology of Kidney Allograft Dysfunction. B. Ivanyi, MD Department of Pathology, University of Szeged, Szeged, Hungary Pathology of Kidney Allograft Dysfunction B. Ivanyi, MD Department of Pathology, University of Szeged, Szeged, Hungary The renal biopsy is a powerful tool in the diagnostic evaluation of allograft dysfunction

More information

Heart Transplant: State of the Art. Dr Nick Banner

Heart Transplant: State of the Art. Dr Nick Banner Heart Transplant: State of the Art Dr Nick Banner Heart Transplantation What is achieved Current challenges Donor scarcity More complex recipients Long-term limitations Non-specific Pharmacological Immunosuppression

More information

Year 2004 Paper one: Questions supplied by Megan

Year 2004 Paper one: Questions supplied by Megan QUESTION 53 Endothelial cell pathology on renal biopsy is most characteristic of which one of the following diagnoses? A. Pre-eclampsia B. Haemolytic uraemic syndrome C. Lupus nephritis D. Immunoglobulin

More information

Case Presentation VASCULITIS. Case Presentation. Case Presentation. Vasculitis

Case Presentation VASCULITIS. Case Presentation. Case Presentation. Vasculitis Case Presentation VASCULITIS The patient is a 24 year old woman who presented to the emergency room with left-sided weakness. She was confused and complained of a severe headache. She was noted to have

More information

2/28/2017. Adult Heart Transplants Donor and Recipient Characteristics UNOS, Retransplant VCM. Other /2015 (N = 24,474)

2/28/2017. Adult Heart Transplants Donor and Recipient Characteristics UNOS, Retransplant VCM. Other /2015 (N = 24,474) 1 46% 2% 3% 4% 0% 2% 2% CHD HCM ICM NICM RCM 49% 3% 3% 3% 1% 3% 3% Retransplant VCM 42% Other 35% 1/1982 6/2015 1/2009 6/2015 2016 JHLT. 2016 Oct; 35(10): 1149-1205 UNOS, 2017 Adult Heart Transplants Donor

More information

Form 4: Coronary Evaluation

Form 4: Coronary Evaluation Patient Details Hidden Show Show/Hide Annotations Form : Coronary Evaluation Print this Form t Started Date of Coronary Evaluation Coronary Evaluation Indication for Coronary Evaluation Check only one.

More information

Form 4: Coronary Evaluation

Form 4: Coronary Evaluation Form : Coronary Evaluation Print this Form t Started Date of Coronary Evaluation Coronary Evaluation Indication for Coronary Evaluation Check only one. Angio NOT DONE: n invasive test performed Followup

More information

Since the first Banff meeting in 1991, the diagnosis and

Since the first Banff meeting in 1991, the diagnosis and CLINICAL AND TRANSLATIONAL RESEARCH Acute Cellular Rejection: Impact of Donor-Specific Antibodies and C4d Michelle Willicombe, 1,5 Candice Roufosse, 2 Paul Brookes, 3 Adam G. McLean 1, Jack Galliford,

More information

VASCULITIS. Case Presentation. Case Presentation

VASCULITIS. Case Presentation. Case Presentation VASCULITIS Case Presentation The patient is a 24 year old woman who presented to the emergency room with left-sided weakness. She was confused and complained of a severe headache. She was noted to have

More information

Vasculitis local: systemic

Vasculitis local: systemic Vasculitis Inflammation of the vessel wall. Signs and symptoms: 1- local: according to the involved tissue 2- systemic:(fever, myalgia, arthralgias, and malaise) Pathogenesis 1- immune-mediated 2- infectious

More information

Primer: histopathology of calcineurin-inhibitor toxicity in renal allografts

Primer: histopathology of calcineurin-inhibitor toxicity in renal allografts Primer: histopathology of calcineurin-inhibitor toxicity in renal allografts Peter Liptak and Bela Ivanyi* SUMMARY Calcineurin inhibitors (ciclosporin and tacrolimus) can cause acute and chronic nephrotoxicity.

More information

James E. Cooper, M.D. Assistant Professor, University of Colorado at Denver Division of Renal Disease and Hypertension, Kidney and PancreasTransplant

James E. Cooper, M.D. Assistant Professor, University of Colorado at Denver Division of Renal Disease and Hypertension, Kidney and PancreasTransplant James E. Cooper, M.D. Assistant Professor, University of Colorado at Denver Division of Renal Disease and Hypertension, Kidney and PancreasTransplant Program Has no real or apparent conflicts of interest

More information

Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients

Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients Pediatr Transplantation 2013: 17: 436 440 2013 John Wiley & Sons A/S. Pediatric Transplantation DOI: 10.1111/petr.12095 Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients

More information

Journal of the American College of Cardiology Vol. 39, No. 6, by the American College of Cardiology Foundation ISSN /02/$22.

Journal of the American College of Cardiology Vol. 39, No. 6, by the American College of Cardiology Foundation ISSN /02/$22. Journal of the American College of Cardiology Vol. 39, No. 6, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)01714-X

More information

Posttransplant Human Leukocyte Antigen Antibodies in Stable Kidney Transplant Recipients

Posttransplant Human Leukocyte Antigen Antibodies in Stable Kidney Transplant Recipients Trends in Transplant. 2014;8:3-9 Gregor Bartel, Georg A. Böhmig: Alloantibodies and Graft Function Posttransplant Human Leukocyte Antigen Antibodies in Stable Kidney Transplant Recipients Gregor Bartel

More information

Incidence of Rejection in Renal Transplant Surgery in the LVHN Population Leading to Graft Failure: 6 Year Review

Incidence of Rejection in Renal Transplant Surgery in the LVHN Population Leading to Graft Failure: 6 Year Review Incidence of Rejection in Renal Transplant Surgery in the LVHN Population Leading to Graft Failure: 6 Year Review Jessica Ludolph 1 Lynsey Biondi, MD 1,2 and Michael Moritz, MD 1,2 1 Department of Surgery,

More information

Marta Farrero Torres₁, Marcelo Pando₂, Dolly Tyan₂, Hannah Valantine₃, Spenser Smith₃, Kiran Khush₃

Marta Farrero Torres₁, Marcelo Pando₂, Dolly Tyan₂, Hannah Valantine₃, Spenser Smith₃, Kiran Khush₃ Development of HLA donor specific antibodies after heart transplantation: importance of a new method to detect the first component of the complement cascade Marta Farrero Torres₁, Marcelo Pando₂, Dolly

More information

Histopathological evaluation of renal allograft biopsies in Nepal: interpretation and significance

Histopathological evaluation of renal allograft biopsies in Nepal: interpretation and significance Nepal Medical Association Building Exhibition Road, Kathmandu Journal of Pathology of Nepal (2012) Vol. 2, 172-179 Association of Clinical Pathologist of Nepal-2010 Journal of PATHOLOGY of Nepal www.acpnepal.com

More information

Supplementary Figure 2

Supplementary Figure 2 100 10 1 0.1 Supplementary Figure 2 ** ** ** * * ** ACTA2 CD34 CSPG4 NCAM TGF-b1 VEGFa Fold-change variation relative to normal tissue Piera Balzarini et al Supplementary Table 1 Pathological features

More information

The diffuse extent of peritubular capillaritis in renal allograft rejection is an independent risk factor for graft loss

The diffuse extent of peritubular capillaritis in renal allograft rejection is an independent risk factor for graft loss http://www.kidney-international.org 2015 International Society of Nephrology see commentary on page 218 The diffuse extent of peritubular capillaritis in renal allograft rejection is an independent risk

More information

Transplantation in highly sensitised patients treated with intravenous immunoglobulin and Rituximab

Transplantation in highly sensitised patients treated with intravenous immunoglobulin and Rituximab ORIGINAL ARTICLE Advance Access publication 1 February 2010 Transplantation in highly sensitised patients treated with intravenous immunoglobulin and Rituximab Ana Carina Ferreira 1, Sandra Brum 1, Vasco

More information

Intruduction PSI MODE OF ACTION AND PHARMACOKINETICS

Intruduction PSI MODE OF ACTION AND PHARMACOKINETICS Multidisciplinary Insights on Clinical Guidance for the Use of Proliferation Signal Inhibitors in Heart Transplantation Andreas Zuckermann, MD et al. Department of Cardio-Thoracic Surgery, Medical University

More information

PREVENTION AND TREATMENT OF BKV NEPHROPATHY Petra Reinke, Berlin, Germany. Chair: Daniel Abramowicz, Brussels, Belgium Rosanna Coppo, Turin, Italy

PREVENTION AND TREATMENT OF BKV NEPHROPATHY Petra Reinke, Berlin, Germany. Chair: Daniel Abramowicz, Brussels, Belgium Rosanna Coppo, Turin, Italy PREVENTION AND TREATMENT OF BKV NEPHROPATHY Petra Reinke, Berlin, Germany Chair: Daniel Abramowicz, Brussels, Belgium Rosanna Coppo, Turin, Italy Prof Petra Reinke Department of Nephrology University Hospital

More information

Evolution of the approaches toward grading and classifying chronic changes in the renal allograft: Banff classification updates III

Evolution of the approaches toward grading and classifying chronic changes in the renal allograft: Banff classification updates III EDITORIAL Advance Access publication 24 February 2014 Evolution of the approaches toward grading and classifying chronic changes in the renal allograft: Banff classification updates III Histopathology

More information

BK virus infection in renal transplant recipients: single centre experience. Dr Wong Lok Yan Ivy

BK virus infection in renal transplant recipients: single centre experience. Dr Wong Lok Yan Ivy BK virus infection in renal transplant recipients: single centre experience Dr Wong Lok Yan Ivy Background BK virus nephropathy (BKVN) has emerged as an important cause of renal graft dysfunction in recent

More information

The Banff Conferences on renal allograft pathology the latest 2013 report

The Banff Conferences on renal allograft pathology the latest 2013 report 615245PSH0010.1177/2010105815615245Proceedings of Singapore HealthcareLoh research-article2015 Review Article PROCEEDINGS OF SINGAPORE HEALTHCARE The Banff Conferences on renal allograft pathology the

More information

Vasculitis local: systemic

Vasculitis local: systemic Vasculitis Inflammation of the vessel wall. Signs and symptoms: 1- local: according to the involved tissue 2- systemic:(fever, myalgia, arthralgias, and malaise) Pathogenesis 1- immune-mediated inflammation

More information

SELECTED ABSTRACTS. All (n) % 3-year GS 88% 82% 86% 85% 88% 80% % 3-year DC-GS 95% 87% 94% 89% 96% 80%

SELECTED ABSTRACTS. All (n) % 3-year GS 88% 82% 86% 85% 88% 80% % 3-year DC-GS 95% 87% 94% 89% 96% 80% SELECTED ABSTRACTS The following are summaries of selected posters presented at the American Transplant Congress on May 5 9, 2007, in San Humar A, Gillingham KJ, Payne WD, et al. Review of >1000 kidney

More information

Peritubular capillaries C4d deposits in renal allograft biopsies and anti HLA I/II alloantibodies screening Incidence and clinical importance

Peritubular capillaries C4d deposits in renal allograft biopsies and anti HLA I/II alloantibodies screening Incidence and clinical importance ORIGINAL ARTICLE Port J Nephrol Hypert 2008; 22(1): 37-42 Peritubular capillaries C4d deposits in renal allograft biopsies and anti HLA I/II alloantibodies screening Incidence and clinical importance Helena

More information

Robert B. Colvin, M.D. Department of Pathology Massachusetts General Hospital Harvard Medical School

Robert B. Colvin, M.D. Department of Pathology Massachusetts General Hospital Harvard Medical School Harvard-MIT Division of Health Sciences and Technology HST.035: Principle and Practice of Human Pathology Dr. Robert B. Colvin Transplantation: Friendly organs in a hostile environment Robert B. Colvin,

More information

Pros and cons for C4d as a biomarker

Pros and cons for C4d as a biomarker review http://www.kidney-international.org & 2012 International Society of Nephrology Pros and cons for C4d as a biomarker Danielle Cohen 1, Robert B. Colvin 2, Mohamed R. Daha 3, Cinthia B. Drachenberg

More information

Clinical impact of de-novo HLA antibodies in pancreas and islet transplantation

Clinical impact of de-novo HLA antibodies in pancreas and islet transplantation Clinical impact of de-novo HLA antibodies in pancreas and islet transplantation David Turner, PhD, FRCPath Lead for H&I Services, Scottish National Blood Transfusion Service Treatment of Type I DM Insulin

More information

Utility of protocol kidney biopsies for de novo donor- specific antibodies

Utility of protocol kidney biopsies for de novo donor- specific antibodies Received: 6 June 2017 Revised: 24 July 2017 Accepted: 29 July 2017 DOI: 10.1111/ajt.14466 BRIEF COMMUNICATION Utility of protocol kidney biopsies for de novo donor- specific antibodies Sandesh Parajuli

More information

Kathryn J. Lindley, 1, 2 Ashwin K. Ravichandran, 1, 2 Joel Schilling, 1, 2, 3 and Susan M. Joseph 1, Introduction

Kathryn J. Lindley, 1, 2 Ashwin K. Ravichandran, 1, 2 Joel Schilling, 1, 2, 3 and Susan M. Joseph 1, Introduction Case Reports in Cardiology Volume 2012, Article ID 639284, 4 pages doi:10.1155/2012/639284 Case Report Antibody-Mediated Rejection of the Heart in the Setting of Autoimmune Demyelinating Polyneuropathy:

More information

Form 4: Coronary Evaluation

Form 4: Coronary Evaluation Page of 7 Patient Details Hidden Show Show/Hide Annotations Stickies: Toggle All Toggle Open Toggle Resolved Form : Coronary Evaluation Print this Form t Started Date of Coronary Evaluation Coronary Evaluation

More information

Dr Ian Roberts Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust

Dr Ian Roberts Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust Dr Ian Roberts Oxford Oxford Pathology Course 2010 for FRCPath Plan of attack: Diagnostic approach to the renal biopsy Differential diagnosis of the clinical syndromes of renal disease Microscopy Step

More information

FIT Board Review Corner March 2016

FIT Board Review Corner March 2016 FIT Board Review Corner March 2016 Welcome to the FIT Board Review Corner, prepared by Sarah Spriet, DO, and Tammy Peng, MD, senior and junior representatives of ACAAI's Fellows-In-Training (FITs) to the

More information

The classification and treatment of antibody-mediated renal allograft injury: Where do we stand?

The classification and treatment of antibody-mediated renal allograft injury: Where do we stand? http://www.kidney-international.org 2007 International Society of Nephrology see original article on page 24 he classification and treatment of antibody-mediated renal allograft injury: Where do we stand?

More information

Mass Histology Service

Mass Histology Service Mass Histology Service A complete anatomical pathology laboratory www.masshistology.com Telephone: (877) 286-6004 Report on Pathology A Time Course Study of the Local Effects of Intramuscular XXXXXXX Injection

More information

Banff VCA Consensus Statements Session

Banff VCA Consensus Statements Session Banff VCA Consensus Statements Session Linda C. Cendales, M.D. Durham, NC, USA On Behalf of the Banff VCA working group Skin Containing VCA as a Monitoring Tool for Intestinal Transplantation Annemarie

More information

3/6/2017. Treatment of Detected Antibodies. I have financial relationship(s) with: Thoratec/St. Jude/Abbott Consultant CareDx Consultant/Speaker

3/6/2017. Treatment of Detected Antibodies. I have financial relationship(s) with: Thoratec/St. Jude/Abbott Consultant CareDx Consultant/Speaker Treatment of Detected Antibodies Sean Pinney, MD Director, Advanced Heart Failure & Transplantation Mount Sinai Hospital New York, NY Sean Pinney, MD Associate Professor of Medicine Icahn School of Medicine

More information

Unusual Causes of Aortic Regurgitation. Case 1

Unusual Causes of Aortic Regurgitation. Case 1 Unusual Causes of Aortic Regurgitation Judy Hung, MD Cardiology Division Massachusetts General Hospital Boston, MA No Disclosures Case 1 54 year old female with h/o cerebral aneurysm and vascular malformation

More information

Impact of Subclinical Rejection on Transplantation

Impact of Subclinical Rejection on Transplantation Trends in Transplantation 2007;1:56-60 Impact of Subclinical Rejection on Transplantation David N. Rush for the Winnipeg Transplant Group Transplant Manitoba Adult Kidney Program, University of Manitoba,

More information

Heart Transplantation

Heart Transplantation Heart Transplantation Abbas Ardehali, M.D., F.A.C.S. Professor of Surgery and Medicine, Division of Cardiac Surgery William E. Connor Chair in Cardiothoracic Transplantation Director, UCLA Heart, Lung,

More information

Form 4: Coronary Evaluation

Form 4: Coronary Evaluation Page of 8 Patient Details Hidden Show Show/Hide Annotations Stickies: Toggle All Toggle Open Toggle Resolved Form : Coronary Evaluation Toggle Question Year/Info Print this Form t Started Date of Coronary

More information

A clinical syndrome, composed mainly of:

A clinical syndrome, composed mainly of: Nephritic syndrome We will discuss: 1)Nephritic syndrome: -Acute postinfectious (poststreptococcal) GN -IgA nephropathy -Hereditary nephritis 2)Rapidly progressive GN (RPGN) A clinical syndrome, composed

More information

Histological Patterns of Polyomavirus Nephropathy: Correlation with Graft Outcome and Viral Load

Histological Patterns of Polyomavirus Nephropathy: Correlation with Graft Outcome and Viral Load American Journal of Transplantation 2004; 4: 2082 2092 Blackwell Munksgaard Copyright C Blackwell Munksgaard 2004 doi: 10.1111/j.1600-6143.2004.00603.x Histological Patterns of Polyomavirus Nephropathy:

More information

Kidneytransplant pathologyrelatedto immunosuppressiveagents

Kidneytransplant pathologyrelatedto immunosuppressiveagents Kidneytransplant pathologyrelatedto immunosuppressiveagents Helmut Hopfer Pathologie Women, 53 years old. 16 months after kidney transplantation for diabetic nephropathy. Metabolicsyndromeandcoronaryheartdisease.

More information

Pathology of Hypertension

Pathology of Hypertension 2016-03-07 Pathology of Hypertension Honghe Zhang honghezhang@zju.edu.cn Tel:88208199 Department of Pathology ❶ Genetic predisposition ❷ Dietary factors ❸ Environmental factors ❹ Others Definition and

More information

Focal peritubular capillary C4d deposition in acute rejection

Focal peritubular capillary C4d deposition in acute rejection Nephrol Dial Transplant (2006) 21: 1382 1388 doi:10.1093/ndt/gfk028 Advance Access publication 5 January 2006 Original Article Focal peritubular capillary C4d deposition in acute rejection Alexander B.

More information

Pathology of Coronary Artery Disease

Pathology of Coronary Artery Disease Pathology of Coronary Artery Disease Seth J. Kligerman, MD Pathology of Coronary Artery Disease Seth Kligerman, MD Assistant Professor Medical Director of MRI University of Maryland Department of Radiology

More information

As outlined under External contributions (see appendix 7.1), the group of Prof. Gröne at the

As outlined under External contributions (see appendix 7.1), the group of Prof. Gröne at the 3 RESULTS As outlined under External contributions (see appendix 7.1), the group of Prof. Gröne at the DKFZ in Heidelberg (Dept. of Cellular and Molecular pathology) contributed to this work by performing

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Loupy A, Lefaucheur C, Vernerey D, et al. Complement-binding

More information

Vasculitis Prof. Dr. med. Katharina Glatz Pathologie

Vasculitis Prof. Dr. med. Katharina Glatz Pathologie Vasculitis 08-21-2018 Prof. Dr. med. Katharina Glatz Pathologie Agenda Anatomy and histology Vasculitis: Chapel Hill Classification Examples Giant cell arteritis Single organ vasculitis Artery or Vein?

More information

Pulmonary Vascular Disease in Systemic Lupus Erythematosus

Pulmonary Vascular Disease in Systemic Lupus Erythematosus Pulmonary Vascular Disease in Systemic Lupus Erythematosus A. OLUSEGUN FAYEMI, M.D.* Department of Pathology, The Mount Sinai School of Medicine of the City University of New York, New York, New York 129

More information